A carregar...
ATIM-31. PHASE I STUDY OF TUMOR TREATMENT FIELDS AND A PERSONALIZED MUTATION-DERIVED TUMOR VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
The tumor microenvironment of a glioblastoma is highly immunosuppressive. Overcoming this immunosuppressive activity seems imperative to a successful treatment. Like other cancers, glioblastoma is capable of generating tumor-specific peptides that can be recognized by the immune system, providing a...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216136/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.026 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|